Search

everythinglearnresearchcommunity

for

Search:↓

3-Deoxysappanchalcone helps human hair cells grow and stimulates hair growth in mice by affecting certain cell signaling pathways.

Substances from Chinese medicines show promise for immune support and disease prevention, but the way they are processed affects their effectiveness.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Hair graying is influenced by factors like nerves, fat cells, and immune cells, not just hair follicles.

Ingenol mebutate gel changes gene expression related to skin development and immune response in actinic keratosis.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Certain drugs increase calcium levels in cancer cells by triggering internal calcium release.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

The Foxn1 gene mutation causes hairlessness and immune system issues, and understanding it could lead to hair growth disorder treatments.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Nanoparticles can speed up wound healing and deliver drugs effectively but may have potential toxicity risks.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Understanding how EDC genes are regulated can help develop better drugs for skin diseases.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Oral retinoids are effective for various skin conditions but have side effects and should not be used during pregnancy.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Children with atopic dermatitis often have sleep problems due to itching and may benefit from melatonin, which helps with sleep and skin symptoms.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

Finasteride affects frog testes by increasing testosterone, decreasing 5α-DHT, and impacting genes related to reproduction and other functions.

Biomaterials combined with stem cells show promise for improving tissue repair and medical treatments.

Exosomes from fat-derived stem cells can potentially improve hair growth and could be a new treatment for immune-related hair loss.

Many adult women suffer from persistent or late-onset acne, and while various treatments exist, finding the right one can be challenging.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.